Sage: Your growth partner for value creation at all stages of your company's lifecycle.
Founded
2001
Sage Partners is an investment firm that collaborates with founders, executives, senior teams, and boards of directors to address critical growth challenges and drive value creation across all stages of a company's lifecycle. Their investment focus includes later-stage rounds, specifically Series B and Series C, supporting companies as they scale and expand their operations.
Notable portfolio companies include AnHeart Therapeutics, which has raised $61 million, and Insilico Medicine, with $255 million in total funding. Sage Partners distinguishes itself through its deep engagement with corporate boards and strategic guidance in mergers and acquisitions (M&A) as part of their growth strategy. The firm’s key partners are seasoned professionals with extensive experience in driving business expansion and value creation.
Sage Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count1
Total Portfolio Exits1
Top Investment Stages
Series B1 (50.0%)
Series C1 (50.0%)
Stage Mix
Series B 50%Series C 50%
Concentration shown as share of disclosed investments by stage.
